PCP (Phencyclidine (angel dust))

Category: Psychedelics. Status: Schedule II (research compound).

A strong dissociative anesthetic developed in the 1950s. Included for completeness and awareness; it carries a high risk of agitation and unpredictable behavior.

How it works

Blocks NMDA glutamate receptors and affects dopamine, producing dissociation, numbness and detachment.

Key facts

• Molecular weight: 243.39 g/mol
• Half-life: Long
• Bioavailability: Oral
• Storage: Research/reference only.

Dosing overview

• Typical dose: Varies by individual and setting
• Frequency: Occasional
• Duration: Acute effects last 4-8 hours (longer at high doses)
• Route: Oral

Protocol notes

• Smoked, swallowed or insufflated; included mainly as a reference dissociative.
• High risk of agitation and unpredictable behavior, so it is not a casual drug.

Reported benefits

• Historic anesthetic research
• Reference dissociative
• Included for awareness

Possible side effects

• Agitation and unpredictable behavior
• Numbness and loss of coordination
• Raised blood pressure
• High risk profile

Compare PCP

• PCP vs MDMA
• PCP vs Psilocybin
• PCP vs LSD
• PCP vs Ibogaine
• PCP vs DMT
• PCP vs Ayahuasca

Research and educational reference only. Not medical advice.